| 1 |
Wu L, Fang Y, Zhang BR. Andersen-Tawil syndrome associated with myopathy. World J Emerg Med. 2020; 11(4):267-9.
doi: 10.5847/wjem.j.1920-8642.2020.04.012
|
| 2 |
Peacock WF, Rafique Z, Clark CL, Singer AJ, Turner S, Miller J, et al. Real world evidence for treatment of hyperkalemia in the emergency department (REVEAL-ED): a multicenter, prospective, observational study. J Emerg Med. 2018; 55(6):741-50.
doi: S0736-4679(18)30923-5
pmid: 30391144
|
| 3 |
Rafique Z, Peacock F, Armstead T, Bischof JJ, Hudson J, Weir MR, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021; 2(5):e12572.
|
| 4 |
Rafique Z, Kosiborod M, Clark CL, Singer AJ, Turner S, Miller J, et al. Study design of Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL-ED): a multicenter, prospective, observational study. Clin Exp Emerg Med. 2017; 4(3):154-9.
doi: 10.15441/ceem.17.207
pmid: 29026889
|
| 5 |
Karmacharya P, Poudel DR, Pathak R, Rettew A, Alweis R. Acute hyperkalemia leading to flaccid paralysis: a review of hyperkalemic manifestations. J Community Hosp Intern Med Perspect. 2015; 5(3):27993.
|
| 6 |
An JN, Lee JP, Jeon HJ, Kim DH, Oh YK, Kim YS, et al. Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care. 2012; 16(6):R225.
doi: 10.1186/cc11872
|
| 7 |
Rafique Z, Chouihed T, Mebazaa A, Frank Peacock W. Current treatment and unmet needs of hyperkalaemia in the emergency department. Eur Heart J Suppl.. 2019; 21(Suppl A):A12-9.
doi: 10.1093/eurheartj/suy029
|
| 8 |
Sidhu K, Sanjanwala R, Zieroth S. Hyperkalemia in heart failure. Curr Opin Cardiol. 2020; 35(2):150-5.
doi: 10.1097/HCO.0000000000000709
|
| 9 |
Alfonzo A, Soar J, MacTier R, Shillday I, Nolan J, et al. Clinical practice guidelines: treatment of acute hyperkalaemia in adults. Available at: https://ukkidney.org.
|
| 10 |
Wang CH, Huang CH, Chang WT, Tsai MS, Yu PH, Wu YW, et al. The effects of calcium and sodium bicarbonate on severe hyperkalaemia during cardiopulmonary resuscitation: a retrospective cohort study of adult in-hospital cardiac arrest. Resuscitation 2016; 98:105-11.
doi: 10.1016/j.resuscitation.2015.09.384
|
| 11 |
Liu MY, Rafique Z. Acute management of hyperkalemia. Curr Heart Fail Rep 2019; 16(3):67-74.
doi: 10.1007/s11897-019-00425-2
|
| 12 |
Rossignol P, Legrand M, Kosiborod M, Hollenberg SM, Peacock WF, Emmett M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res 2016; 113(Pt A):585-91.
doi: S1043-6618(16)30723-X
pmid: 27693804
|
| 13 |
Long B, Warix JR, Koyfman A. Controversies in management of hyperkalemia. J Emerg Med. 2018; 55(2):192-205.
doi: 10.1016/j.jemermed.2018.04.004
|
| 14 |
Sterns RH, Grieff M, Bernstein PL. Treatment of hyperkalemia: something old, something new. Kidney Int. 2016; 89(3):546-54.
doi: 10.1016/j.kint.2015.11.018
|
| 15 |
Mandelberg A, Krupnik Z, Houri S, Smetana S, Gilad E, Matas Z, et al. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest. 1999; 115(3):617-22.
|
| 16 |
Greenberg A. Hyperkalemia: treatment options Semin Nephrol. 1998; 18(1):46-57.
pmid: 9459288
|
| 17 |
Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int. 1992; 41(2):369-74.
pmid: 1552710
|
| 18 |
Lindner G, Burdmann EA, Clase CM, Hemmelgarn BR, Herzog CA, Małyszko J, et al. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes Conference. Eur J Emerg Med. 2020; 27(5):329-37.
doi: 10.1097/MEJ.0000000000000691
pmid: 32852924
|
| 19 |
Gruy-Kapral C, Emmett M, Santa Ana CA, Porter JL, Fordtran JS, Fine KD. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol. 1998; 9(10):1924-30.
doi: 10.1681/ASN.V9101924
pmid: 9773794
|
| 20 |
Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol. 2010; 21(5):733-5.
doi: 10.1681/ASN.2010010079
|
| 21 |
Rafique Z, Liu MY, Staggers KA, Minard CG, Peacock WF. Patiromer for treatment of hyperkalemia in the emergency department: a pilot study. Acad Emerg Med. 2020; 27(1):54-60.
doi: 10.1111/acem.13868
pmid: 31599043
|
| 22 |
Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA. 2014; 312(21):2223-33.
doi: 10.1001/jama.2014.15688
pmid: 25402495
|
| 23 |
Cooper K. Letter to the editor regarding “patiromer for the treatment of hyperkalemia”. Expert Rev Clin Pharmacol. 2020; 13:1283-4.
doi: 10.1080/17512433.2020.1828542
|
| 24 |
Pergola PE, Spiegel DM, Warren S, Yuan JW, Weir MR. Patiromer lowers serum potassium when taken without food: comparison to dosing with food from an open-label, randomized, parallel group hyperkalemia study. Am J Nephrol. 2017; 46(4):323-32.
doi: 10.1159/000481270
pmid: 29017162
|
| 25 |
Pirklbauer M. Hemodialysis treatment in patients with severe electrolyte disorders: management of hyperkalemia and hyponatremia. Hemodial Int. 2020; 24(3):282-9.
doi: 10.1111/hdi.12845
pmid: 32436307
|
), Joseph Harold Walline2(
